Copyright
©The Author(s) 2024.
World J Diabetes. Aug 15, 2024; 15(8): 1717-1725
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1717
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1717
Table 5 Frequency of antibody positivity, n (%)
| Variable | Total (n = 132) | No insulin dependence (n = 64) | Insulin dependent (n = 68) | P value |
| Anti-GAD 65 | 39 (29.5) | 13 (20.3) | 26 (38.2) | 0.02 |
| Anti-IA2 | 24 (18.2) | 8 (12.5) | 16 (23.5) | 0.07 |
| Anti-Zn8T | 21 (15.9) | 3 (4.7) | 18 (26.5) | 0 |
| Anti-GAD65 + anti-IA2 | 20 (15.2) | 5 (7.8) | 15 (22.1) | 0.02 |
| Anti-GAD65 + anti-Zn8T | 15 (11.4) | 3 (4.7) | 12 (17.6) | 0.01 |
| Anti-IA2 + anti-Zn8T | 12 (9.1) | 2 (3.1) | 10 (14.7) | 0.02 |
| Three antibodies | 12 (9.1) | 2 (3.1) | 10 (14.7) | 0.02 |
- Citation: Molina JM, Medina PG, Gomez RA, Herrera JR, Martínez NL, Hernández B, García Y. Autoantibodies against beta cells to predict early insulin requirements in pediatric patients with clinically diagnosed type 2 diabetes. World J Diabetes 2024; 15(8): 1717-1725
- URL: https://www.wjgnet.com/1948-9358/full/v15/i8/1717.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i8.1717